MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-142807 | Others
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Molecular diagnosis in infectious disease detection Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET
7.1 GLOBAL MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA MOLECULAR DIAGNOSIS IN INFECTIOUS DISEASE DETECTION MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Genomix Biotech
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Abbott
16.3 BD
16.4 Luminex
16.5 GenMark Diagnostics
16.6 Veridex
16.7 Qiagen
16.8 Roche
16.9 BioMerieux
16.10 BioTheranostics
16.11 Thermo Fisher Scientific
16.12 Siemens
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredIsothermal nucleic acid amplification technique
Next generation sequencing
microarray
other
polymerase chain reaction
hybridization
Major Downstream Industry Covered
hospital
Academic institutions
other
laboratory
clinic
Companies
Genomix Biotech
Abbott
BD
Luminex
GenMark Diagnostics
Veridex
Qiagen
Roche
BioMerieux
BioTheranostics
Thermo Fisher Scientific
Siemens
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.